Division of Anatomic Pathology and Histology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
Division of Anatomic Pathology, Department of Pathology, Virginia Commonwealth University Health System, Richmond, Virginia, USA.
Cancer Cytopathol. 2020 Sep;128(9):637-641. doi: 10.1002/cncy.22291.
The 8th Annual National Molecular Cytopathology Meeting, held in Naples, Italy, on December 2 to 3, 2019, addressed updates in diagnostic cytopathology and molecular classifications and specifically focused on lung cancer biomarker testing in cytology samples. Lung cancer continues to be the most commonly diagnosed noncutaneous malignancy in the world. In the majority of patients, lung cancers are frequently identified when they cannot be surgically accessed, and this leads to the use of cytology for a diagnosis and theragnostic testing. The meeting was an international forum for discussing new roles and updates for cytopathology in molecular testing as the basis for provoking new trends and novel approaches. The relevant literature is referenced. The significance of these updates for the practice of pathology in general is discussed.
2019 年 12 月 2 日至 3 日，第八届年度全国分子细胞病理学会议在意大利那不勒斯举行，会议主要讨论了诊断细胞病理学和分子分类方面的最新进展，特别关注了细胞学样本中肺癌生物标志物检测。肺癌仍然是世界上最常见的非皮肤恶性肿瘤。在大多数患者中，当肺癌无法通过手术治疗时，通常会通过细胞学检查来进行诊断和治疗检测。本次会议是一个国际性的论坛，旨在讨论分子检测中细胞病理学的新作用和更新，为引发新趋势和新方法提供基础。本文引用了相关文献。并讨论了这些更新对一般病理学实践的意义。
